Physician profile
James Dallis
NPI 1003850496
$2,660.06
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.48 · 2021: $1,208 · 2022: $64.01 · 2023: $120 · 2024: $1,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,130 · Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,129.90 |
| Food and Beverage | $208.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $1,200.00 | 2021 | |
| Peerless Surgical INC. | $1,174.90 | 2024 | |
| Depuy Synthes Sales INC. | $57.29 | 2019-2023 | Tfn-Advance |
| Convatec INC. | $57.02 | 2022-2023 | |
| Smith+Nephew, INC. | $44.19 | 2024 | Real Intelligence |
| Zimvie INC. | $43.92 | 2023 | |
| Orthofix Medical, INC. | $19.67 | 2019-2021 | |
| Vericel Corporation | $18.72 | 2022 | |
| Bioventus LLC | $18.14 | 2022 | |
| Heron Therapeutics, INC. | $14.53 | 2023 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.